Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 13;18(6):700.
doi: 10.1186/s13054-014-0700-0.

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

Andrés Cárdenas  1 , Elsa Solà  2 , Ezequiel Rodríguez  3 , Rogelio Barreto  4 , Isabel Graupera  5 , Marco Pavesi  6 , Faouzi Saliba  7 , Tania Mara Welzel  8 , Javier Martinez-Gonzalez  9 , Thierry Gustot  10 , Mauro Bernardi  11 , Vicente Arroyo  12 , Pere Ginès  13   14 ; CANONIC study investigators of the EASL-CLIF Consortium
Affiliations

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

Andrés Cárdenas et al. Crit Care. .

Abstract

Introduction: Hyponatremia is a marker of poor prognosis in patients with cirrhosis. This analysis aimed to assess if hyponatremia also has prognostic value in patients with acute-on-chronic liver failure (ACLF), a syndrome characterized by acute decompensation of cirrhosis, organ failure(s) and high short-term mortality.

Methods: We performed an analysis of the Chronic Liver Failure Consortium CANONIC database in 1,341 consecutive patients admitted to 29 European centers with acute decompensation of cirrhosis (including ascites, gastrointestinal bleeding, hepatic encephalopathy, or bacterial infections, or any combination of these), both with and without associated ACLF (301 and 1,040 respectively).

Results: Of the 301 patients with ACLF, 24.3% had hyponatremia at inclusion compared to 12.3% of 1,040 patients without ACLF (P <0.001). Model for end-stage liver disease, Child-Pugh and chronic liver failure-SOFA scores were significantly higher in patients with ACLF and hyponatremia compared to those without hyponatremia. The presence of hyponatremia (at inclusion or during hospitalization) was a predictive factor of survival both in patients with and without ACLF. The presence of hyponatremia and ACLF was found to have an independent effect on 90-day survival after adjusting for the potential confounders. Hyponatremia in non-ACLF patients nearly doubled the risk (hazard ratio (HR) 1.81 (1.33 to 2.47)) of dying at 90 days. However, when considering patients with both factors (ACLF and hyponatremia) the relative risk of dying at 90 days was significantly higher (HR 6.85 (3.85 to 12.19) than for patients without both factors. Patients with hyponatremia and ACLF had a three-month transplant-free survival of only 35.8% compared to 58.7% in those with ACLF without hyponatremia (P <0.001).

Conclusions: The presence of hyponatremia is an independent predictive factor of survival in patients with ACLF. In cirrhosis, outcome of patients with ACLF is dependent on its association with hyponatremia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Algorithm of all patients enroled and categorized by the presence of acute-on-chronic liver failure (ACLF) at inclusion and the subsequent development of hyponatremia after inclusion.
Figure 2
Figure 2
Transplant-free survival curves in patients with and without acute-on-chronic liver failure (ACLF) according to the presence of hyponatremia at inclusion. CLIF: chronic liver failure; CLIF-SOFA: chronic liver failure-sequential organ failure assessment; HR: hazard ratio; MELD: model for end-stage liver disease.
See this image and copyright information in PMC

References

    1. Ginès P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48:1002–1010. doi: 10.1002/hep.22418. - DOI - PubMed
    1. European Association for the Study of the Liver EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417. doi: 10.1016/j.jhep.2010.05.004. - DOI - PubMed
    1. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55:vi1–12. doi: 10.1136/gut.2006.099580. - DOI - PMC - PubMed
    1. Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, Galeras JA, Giménez MD, Santos J, Cirera I, Morillas RM, Coll S, Solà R. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385–1394. doi: 10.1016/j.cgh.2006.08.007. - DOI - PubMed
    1. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802–810. doi: 10.1002/hep.1840400409. - DOI - PubMed

Publication types